8 Hour Buprenorphine Training (Tacoma, WA)
If you are interested in attending this training please contact Dr. Pentin at [email protected]
8 Hour Buprenorphine Training (Spokane, WA)
If you are interested in attending this training please contact Dr. Pentin at [email protected]
8 Hour Buprenorphine Training (Anchorage, AK)
If interested in attending please contact Dr. Pentin at [email protected]
8 Hour Buprenorphine Training (Kealakekua, HI)
If you are interested in attending please contact Dr. Pentin at [email protected]
Rethinking the Role of Family in Addiction Care
Social and family support are predictors of treatment retention, sustained recovery, and improved quality of life for persons with substance use disorder. Yet, family members are not engaged in addiction treatment settings to improve their health or that of their loved ones. It is important for addiction care teams to understand how information and education provided to family members can impact the course of a loved one’s treatment and recovery. Some basic changes can be made to integrate this invaluable resource into addiction care.
Xylazine and How it Harms People Who Use Drugs
We will review what is known to date on Xylazine, a CNS depressant, which has been linked to an increasing number of overdose deaths in the US. This Roundtable will discuss its physiologic effects, and risk of xylazine harms including overdose and wounds along with suggested clinical best practices for providers and patients.
PCSS Exchange Session 1 – Explore, Part 1
Facilitator: Sherry Larkins, PhD, Director of International Programs and Research Sociologist, Integrated Substance Abuse Programs at the University of California, Los Angeles – Semel Institute for Neuroscience and Human Behavior Cost: No fee Target Audience: Physicians, nurse practitioners or other advanced practice nurses, PAs, psychologists, social workers, clinical administrators and healthcare teams. Credit Designations Available: AMA PRA Category 1 […]
